Portfolio of the week - 2007

[peanuts]

Dear Mr. Rob, sir

Congrats to the top 2. The third place winner is only there because of luck, so I'll give congrats to #4 as well as the other top contestants this week!

Once again, the scorekeeping is a source of entertainment and information. Thanks, Rob! Keep up the great work. I never would have known about Dog (or is it "Dawg"?) without you. I have to ask a favor of you. After Nov 6, I will not be in the position to post to Mr Market's site again until Nov 17th. I request to be put into a CA$H position for the market week of Nov 12-16.

Due to my absence from the site, I will not be able to update the POTW yearly standings until the end next week, either, but will completely update them when I can.

Speaking of dogs, for this upcoming week, I would like to begin with a real dog, but as a long position- gimme RAD, long please.

Thanks for taking great care of things, Rob.



***The yearly standings are updated***

[jiesen]

Wow, by just 0.1% - talk about a close one! Congrats, Stky, on edging NBB out for the gold. Nice job Newborn and Peanuts, too!

Rob, please put me inLJPC long for this week. Thanks!

[New-born baby]

Wow, by just 0.1% - talk about a close one! Congrats, Stky, on edging NBB out for the gold. Nice job Newborn and Peanuts, too!

Rob, please put me inLJPC long for this week. Thanks!

Jiesen,
Whatever happened to AMLN? Looking short to $36 on this once high flier.

[JohnHenry]

Btj

Wow, by just 0.1% - talk about a close one! Congrats, Stky, on edging NBB out for the gold. Nice job Newborn and Peanuts, too!

Rob, please put me inLJPC long for this week. Thanks!

Yeah Wow! Just 0.1%. Congrats to all in the green.

Please short BTJ...thanks for keeping score Rob.

[let-it-ride]

I'll go with NXG long. Thanks.

[ywamchris]

I'll Stick it out again....

I'll short WBMD again. It's bound to have another significant drop. The only thing the stock has going for it is that the analysts love it. I'm banking on the fact that it misses earnings...

[mimo_100]

I will start in CA$H

I will start in CA$H, Thank you.

[Rob]

Get Those Picks In ...

Of the recent regulars in the contest only two are still M.I.A.

Doug? What'll it be?

Karel? What'll it be? PCU long?

[New-born baby]

Yeah Wow! Just 0.1%. Congrats to all in the green.

Please short BTJ...thanks for keeping score Rob.

BTJ looks promising as a short.
RAD is one ugly chart, Peanuts. 10 down weeks in a row. But it is at a support, and for a one week play, it might be a winnah for you. But nothing I'd stake my money on right now based on the chart. Are the fundamentals improving at RAD?

[Karel]

Of the recent regulars in the contest only two are still M.I.A.

Doug? What'll it be?

Karel? What'll it be? PCU long?

Thank you Rob. Yes, please: long PCU.

Regards,

Karel

[stenzrob]

ININ long, please.

[IIC]

EGI long....IIC

[stenzrob]

Newborn,
I see AOB headed down after hours.
Guess the report is not what was expected.
Haven't examined it yet, but AOB's long run may be at an end.
regards ... stenz

[jiesen]

Speaking of broken stuff looking like it may recover . . . MFLX, IF it can clear $15, looks the bull to $23.

And speaking of broken things, take a look at GRMN taking an $8 haircut this mornin'.

nice call on the MFLX, NBB!

http://finance.yahoo.com/q/bc?s=MFLX&t=5d

nearly hit 20 today.

[jiesen]

Jiesen,
Whatever happened to AMLN? Looking short to $36 on this once high flier.

AMLN is getting taken down hard on good news. Just like it did when Byetta and Symlin were approved. Stock tanked from $25 to 15 (or something like that) and it provided me a great entry at $20.

http://biz.yahoo.com/prnews/071031/law097.html?.v=101

Now it's the same thing, imo. Byetta LAR (Long-acting release version) clinical data just came in, says it's better than Byetta, and so someone is dropping the price... perhaps trying to exit a big short, or buy a big piece of the company on the cheap.

AMLN is a bargain at $41, but that doesn't mean it won't go to $30 before taking off again.

Sales will pick up with Byetta LAR, but it will take a couple of years. Approval is still not guaranteed, but it should happen in 2009. With once per week injections, instead of twice daily, there will be little excuse left for doctors not to prescribe it. Plus, it works better at controlling glucose levels! Many people using Byetta now are reducing, or even eliminating their need for insulin injections. I don't think the competing drugs (Januvia) are able to do the same.

The reason Januvia is outselling Byetta now is mostly the inconvenience of the injections vs the convenience of Januvia's pill form, but also because of the weight of MRK's marketing machine. When people wise up and realize which drug actually performs better, the sales will finally reflect it.

I still think AMLN is a great stock to own, and still own my $20 shares. However, LJPC offers a much greater opportunity for weekly triple-digit gains, which is what I'm hoping to get here (one of these days). When positive Riquent results are announced (and they should be someday soon) the stock has the potential to jump from $4 to $40 in a month, week, or even a day. I would hate to be out of LJPC on that day...